ID

24582

Beschrijving

Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00474708

Link

https://clinicaltrials.gov/show/NCT00474708

Trefwoorden

Versies (1)
  1. 07-08-17 07-08-17 -
Geüploaded op

7 augustus 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Major Depressive Disorder NCT00474708

Engels

Eligibility Major Depressive Disorder NCT00474708

1 Formulieren  
Criteria
Beschrijving

Criteria

males or females, 18 -65 years of age
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
outpatients
Beschrijving

Outpatients

Datatype

boolean

Alias
UMLS CUI [1]
C0029921
major depressive disorder based on dsm-iv criteria
Beschrijving

Major Depressive Disorder

Datatype

boolean

Alias
UMLS CUI [1]
C1269683
the baseline score of 17-item ham-d³17
Beschrijving

Hamilton Depression Rating Scale 17 Item Questionnaire

Datatype

boolean

Alias
UMLS CUI [1]
C3639712
switchers from prior antidepressants, who have had no satisfactory improvement (normally after a minimum of 8weeks of treatment), with an approved antidepressant medication or have experienced intolerance due to side effects to their antidepressant medication based on clinical discretion
Beschrijving

Change of medication | Antidepressive Agents Unsatisfactory | Intolerance to Antidepressive Agents | Adverse reaction to Antidepressive Agents

Datatype

boolean

Alias
UMLS CUI [1]
C0580105
UMLS CUI [2,1]
C0003289
UMLS CUI [2,2]
C0439856
UMLS CUI [3,1]
C1744706
UMLS CUI [3,2]
C0003289
UMLS CUI [4,1]
C0041755
UMLS CUI [4,2]
C0003289
provide written informed consent
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
if female is of childbearing potential, must be confirmed no pregnancy at baseline, and use a medically acceptable method of contraception throughout the study.
Beschrijving

Childbearing Potential Pregnancy test negative Contraceptive methods

Datatype

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
UMLS CUI [1,3]
C0700589
main exclusion criteria:
Beschrijving

Exclusion Criteria Main

Datatype

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
hypersensitivity to venlafaxine;
Beschrijving

Venlafaxine allergy

Datatype

boolean

Alias
UMLS CUI [1]
C0570764
clinically significant renal or hepatic disease or any other medical disease that, in the opinion of the investigator, might compromise the study, including seizure
Beschrijving

Kidney Disease | Liver disease | Disease compromises Clinical Trial | Seizures

Datatype

boolean

Alias
UMLS CUI [1]
C0022658
UMLS CUI [2]
C0023895
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C2945640
UMLS CUI [3,3]
C0008976
UMLS CUI [4]
C0036572
alcohol or drug abuse within the last year
Beschrijving

Substance Use Disorders

Datatype

boolean

Alias
UMLS CUI [1]
C0038586
a recent history of myocardial infarction or unstable heart disease (within 6 months of baseline)
Beschrijving

Myocardial Infarction | Heart Disease Unstable

Datatype

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2,1]
C0018799
UMLS CUI [2,2]
C0443343
bipolar disorder
Beschrijving

Bipolar Disorder

Datatype

boolean

Alias
UMLS CUI [1]
C0005586
for female, known or suspected pregnancy or breast feeding
Beschrijving

Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
use of a monoamine oxidase inhibitor (maoi) within 14 days of baseline; use of any investigational drug within 30 days of baseline.
Beschrijving

Monoamine Oxidase Inhibitors | Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1]
C0026457
UMLS CUI [2]
C0013230
patients have prior use of venlafaxine or use of venlafaxine for the current episode.
Beschrijving

venlafaxine | Single major depressive episode

Datatype

boolean

Alias
UMLS CUI [1]
C0078569
UMLS CUI [2]
C0024517
Terug naar het begin van de pagina

Similar models

Eligibility Major Depressive Disorder NCT00474708

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Age
Item
males or females, 18 -65 years of age
boolean
C0001779 (UMLS CUI [1])
Outpatients
Item
outpatients
boolean
C0029921 (UMLS CUI [1])
Major Depressive Disorder
Item
major depressive disorder based on dsm-iv criteria
boolean
C1269683 (UMLS CUI [1])
Hamilton Depression Rating Scale 17 Item Questionnaire
Item
the baseline score of 17-item ham-d³17
boolean
C3639712 (UMLS CUI [1])
Change of medication | Antidepressive Agents Unsatisfactory | Intolerance to Antidepressive Agents | Adverse reaction to Antidepressive Agents
Item
switchers from prior antidepressants, who have had no satisfactory improvement (normally after a minimum of 8weeks of treatment), with an approved antidepressant medication or have experienced intolerance due to side effects to their antidepressant medication based on clinical discretion
boolean
C0580105 (UMLS CUI [1])
C0003289 (UMLS CUI [2,1])
C0439856 (UMLS CUI [2,2])
C1744706 (UMLS CUI [3,1])
C0003289 (UMLS CUI [3,2])
C0041755 (UMLS CUI [4,1])
C0003289 (UMLS CUI [4,2])
Informed Consent
Item
provide written informed consent
boolean
C0021430 (UMLS CUI [1])
Childbearing Potential Pregnancy test negative Contraceptive methods
Item
if female is of childbearing potential, must be confirmed no pregnancy at baseline, and use a medically acceptable method of contraception throughout the study.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
Exclusion Criteria Main
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Venlafaxine allergy
Item
hypersensitivity to venlafaxine;
boolean
C0570764 (UMLS CUI [1])
Kidney Disease | Liver disease | Disease compromises Clinical Trial | Seizures
Item
clinically significant renal or hepatic disease or any other medical disease that, in the opinion of the investigator, might compromise the study, including seizure
boolean
C0022658 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
C0012634 (UMLS CUI [3,1])
C2945640 (UMLS CUI [3,2])
C0008976 (UMLS CUI [3,3])
C0036572 (UMLS CUI [4])
Substance Use Disorders
Item
alcohol or drug abuse within the last year
boolean
C0038586 (UMLS CUI [1])
Myocardial Infarction | Heart Disease Unstable
Item
a recent history of myocardial infarction or unstable heart disease (within 6 months of baseline)
boolean
C0027051 (UMLS CUI [1])
C0018799 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
Bipolar Disorder
Item
bipolar disorder
boolean
C0005586 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
for female, known or suspected pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Monoamine Oxidase Inhibitors | Investigational New Drugs
Item
use of a monoamine oxidase inhibitor (maoi) within 14 days of baseline; use of any investigational drug within 30 days of baseline.
boolean
C0026457 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
venlafaxine | Single major depressive episode
Item
patients have prior use of venlafaxine or use of venlafaxine for the current episode.
boolean
C0078569 (UMLS CUI [1])
C0024517 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial